26,927 findings
- MolecularStrong
High-circulating lipid availability results in lower peak aminoacidemia following protein ingestion.
Understanding the impact of lipid levels on amino acid availability can inform dietary strategies.
Supports 2019 - MolecularStrong
Semaglutide has a higher pooled reporting odds ratio (ROR) for gastrointestinal adverse drug reactions (GADRs) compared to liraglutide (5.53 vs 3.95).
Clinicians should consider the higher gastrointestinal risk associated with semaglutide when prescribing.
Supports 2022 - MolecularStrong
Semaglutide has a later pooled time-to-onset median of GADRs compared to liraglutide (7 days vs 4 days).
Healthcare providers should be aware of the delayed onset of gastrointestinal issues with semaglutide.
Supports 2022 - Energy balanceStrong
Recommendations for incorporating genetics and genomics into clinical decision-making for behavioral weight loss are outlined.
Practitioners can consider these recommendations to enhance behavioral weight loss interventions.
Supports 2018 - HormonalStrong
Naltrexone/bupropion increased proglucagon levels and decreased GLP-2, glucagon, and the major proglucagon fragment.
Naltrexone/bupropion may be beneficial for altering specific hormone levels related to metabolism.
Supports 2023 - Metabolic adaptationStrong
Gastric bypass surgery has positive effects that cannot be solely explained by caloric restriction.
Practitioners should consider factors beyond caloric intake when evaluating gastric bypass outcomes.
Supports 2018 - CellularStrong
Gut-derived signals significantly modulate outcomes after bariatric surgery.
Understanding gut-derived signals can help in developing interventions for obesity.
Supports 2018 - CellularStrong
High responders to hypertrophic strength training showed a decrease of -10.5% in vastus lateralis cross-sectional area (VLCSA) during detraining.
Practitioners should be aware that high responders may experience significant muscle loss during periods of detraining.
Supports 2021 - MolecularStrong
DEPTOR is identified as a critical mechanistic candidate for disuse-driven MPS suppression.
Targeting DEPTOR may offer a therapeutic approach to counteract muscle loss during periods of disuse.
Supports 2021 - Energy balanceStrong
Lifestyle interventions and older antiobesity pharmacotherapies have been associated with less than 12% body weight reduction and no clear benefit to reduce MACE risk.
Practitioners should be aware that traditional weight loss methods may not significantly reduce cardiovascular risks.
Supports 2023 - HormonalStrong
Retatrutide increased heart rate by up to 6.7 beats/min, which may offset some benefits of weight loss.
Weight loss treatments like retatrutide may have cardiovascular implications that need to be considered.
Qualifies 2023 - Energy balanceStrong
Barriers to providing advice on specific dietary patterns for T2DM include safety and compliance challenges.
Dietitians should be aware of and address safety and compliance issues when advising patients.
Supports 2021 - CellularStrong
Common cardiovascular conditions, such as heart failure with preserved ejection fraction, can be conceptualized as a consequence of accelerated aging.
Understanding the link between aging and heart failure can guide prevention and management strategies.
Supports 2025New - Metabolic adaptationStrong
Both CLA and placebo groups improved oxygen uptake after the 8-week intervention.
Aerobic exercise is beneficial for improving oxygen uptake in obese women.
Supports 2015 - CellularStrong
Genetic predisposition to higher waist-to-hip ratio adjusted for BMI (WHRadjBMI) predicts an increase in waist circumference after weight loss.
Practitioners should consider genetic predisposition when assessing potential waist circumference changes after weight loss.
Supports 2023 - Energy balanceStrong
Genetic predisposition to higher BMI does not predict weight regain after weight loss.
Genetic factors related to BMI may not be useful for predicting weight regain, focusing instead on abdominal obesity genetics.
Refutes 2023 - Energy balanceStrong
Genetic effects on abdominal obesity may be more pronounced than those on general obesity during weight regain.
Understanding the differential impact of genetics on abdominal versus general obesity can inform targeted interventions.
Supports 2023 - CellularStrong
Remission of diabetes may not be permanent and can result in glycemic relapse over time.
Clinicians should communicate the potential for relapse when discussing remission with patients.
Qualifies 2023 - Energy balanceStrong
Companies can profit from CCT programs by selling enrollment as self-commitment devices.
Businesses can leverage CCT programs as a market opportunity while promoting healthier behaviors.
Supports 2021 - Energy balanceStrong
There is a need for sport event organizers to question and challenge claims of health promotion.
Sport organizations should critically evaluate their health promotion strategies and claims.
Supports 2019 - Energy balanceStrong
Researchers have failed to reach a consensus on the potential benefits of fad diets for weight loss.
Practitioners should be cautious in recommending fad diets for weight loss due to lack of consensus on their efficacy.
Refutes 2001 - Energy balanceStrong
Fad diets vary widely in their approaches, including very low carbohydrate and very low fat options.
Practitioners should be aware of the diverse types of fad diets when discussing dietary options with patients.
Supports 2001 - Energy balanceStrong
An inverse relationship was found between the sitting height to total height ratio and the SDL:CDL strength ratio.
Individuals with longer torsos may benefit more from the SDL.
Supports 2019 - HormonalStrong
NN1706 lowers body weight & improves glycemic control in obese rodents and monkeys.
NN1706 may also be beneficial for weight management and glycemic control in animal models of obesity.
Supports 2025New